-
First in Europe - Innovative Vision Postbiotic EYEMUSE® to Combat Digital Eye Fatigue
Supersmart, a leading name in the field of dietary supplements and nutritional products, is proud to announce the launch of its groundbreaking product, Vision Postbiotic EYEMUSE®...
-
IMMUSE Postbiotic Wins Inaugural “Microbiome Modulation” Industry Award
IMMUSE postbiotic for immune health, has been honored as the inaugural recipient of the the Ingredient of the Year: Microbiome Modulation category...
-
Introducing Rebound: Your Ultimate Party Recovery Solution Featuring Setria® Glutathione
A new supplement concept to help you elevate your party recovery experience and unlock your body’s full potential in the days that follow.
-
Comple.med Launches the First Food Supplement in Europe Featuring IMMUSE®
Kyowa Hakko’s IMMUSE®, a clinically researched unique postbiotic, provides immune support in Lactoflor® Immuno 200...
-
Manufacturing strains of Kyowa Hakko Bio’s 3'-sialyllactose and 6’-sialyllactose, human milk oligosaccharides (HMOs), passed safety evaluation in China
KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strains used for producing 3'-sialyllactose (3’-SL) and 6’-sialyllactose (6’-SL) have passed the Chinese Ministry of Agriculture and Rural affairs’ (MARA) safety evaluation...
-
Completion Of Human Milk Oligosaccharides (HMOs) Production Facility
KYOWA HAKKO BIO CO. LTD. (Kyowa Hakko Bio), a subsidiary of Kirin Holdings Company, Limited (Kirin Holdings), completed a production facility for human milk oligosaccharides (HMOs) on November 18, 2022 at its Thai subsidiary, THAI KYOWA BIOTECHNOLOGIES CO., LTD.
-
Manufacturing strain of Kyowa Hakko Bio’s 2'-fucosyllactose, a human milk oligosaccharide (HMO), passed safety evaluation in China.
KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strain used for producing 2'-fucosyllactose (2’-FL), the most abundant HMO in human milk, has passed the safety...
-
Cognizin® Citicoline - NutraIngredients Award Winner Europe 2022
Kyowa Hakko Europe, a leading international health ingredient manufacturer, is pleased to announce this prestigious NutraIngredients Award given to its flagship product Cognizin® Citicoline...
-
Kyowa Hakko Announces the Appointment of Dr. Colin Hill to the Scientific Advisory Board of Award-Winning Postbiotic IMMUSE™
With an impressive background in mining the microbiome for novel therapies, Prof. Hill helped with the definition of a postbiotic as a part of ISAPP.
-
New Research Suggests Kyowa Hakko Bio’s Cognizin® Citicoline Aids in Memory Function
Findings published in The Journal of Nutrition demonstrate supplementation of citicoline for improved overall memory performance in healthy elderly populations.

News